Synthesis of novel piperazino-alkyl-1H-benzo[d]imidazole derivates and assessment of their interactions with the D2 dopamine receptor

Jelena Z. Penjiševic, Deana B. Andrić, Vladimir B. Šukalović, Goran M. Roglić, Vukić Šoškić, Slađana Kostić-Rajačić


A total of 14 novel arylpiperazines were synthesized, and pharmaco­logic­ally evaluated by measuring their affinities towards the D2 dopamine receptor (D2DR) in a [3H]spiperone competition assay. All herein described compounds consist of a benzimidazole moiety connected to the N-(2-methoxyphenyl)pipe­razine via linkers of various lengths. Molecular docking analysis and molecular dynamics simulations were performed on D2DR-arylpiperazine complexes with an objective to explore the receptor-ligand interactions and properties of the receptor binding site. Crystal structure of D2DR that has been published recently was used throughout this study.

The major finding is that high affinity arylpiperazines must interact with both the orthosteric binding site and the extended binding pocket of D2DR and therefore should contain a linker of 5 or 6 methylene groups long.


arylpiperazines; molecular dynamics; molecular docking; receptor bind site

Full Text:

PDF (1,591 kB)


N. M. Urs, S. M. Peterson, M. G. Caron, Biol. Psychiatry 81 (2017) 78 (

J. M. Beaulieu, R. R. Gainetdinov, Pharmacological Reviews 63 (2011) 182 (

S. Reeves, E. McLachlan, J. Bertrand, F. D’Antonio, S. Brownings, A. Nair, S. Greaves, A. Smith, D. Taylor, J. Dunn, at al., Brain 140 (2017) 1117 (

S.M. Stahl, CNS Spectrums 22 (2017) 305 (

M. C. Lagerström, H. B. Schiöth, Nat. Rev. Drug Discov. 7 (2008) 339 (

J. P. Kesby, D. W. Eyles, J. J. McGrath, J. G. Scott, Transl. Psychiatry (2018) 8:30 (

E. Tomasella, L. Bechelli, M. B. Ogando, C. Mininni, M. N. Di Guilmi, F. De Fino, at al., Proc. Natl. Acad. Sci. 115 (2018) 3476 (

C. D. J. Kusters, K. C. Paul, I. Guella, J. M. Bronstein, J. S. Sinsheimer, M. J. Farrer, et al., Park. Relat. Disord. 47 (2018) 39 (

V. Soskic, V. Sukalovic, S. Kostic-Rajacic, Mini Rev. Med. Chem. 15 (2015) 988 (

X. Chen, M. F. Sassano, L. Zheng, V. Setola, M. Chen, X. Bai, at al., J. Med. Chem. 55 (2012) 7141 (

M. Marcinkowska, M. Kotańska, A. Zagórska, J’ Śniecikowska, M. Kubacka, A. Siwek at all , J. Enzyme Inhib. Med. Chem. 33 (2018) 536 (

G. Chłoń-Rzepa, A. Bucki, M. Kołaczkowski, A. Partyka, M. Jastrzębska-Więsek, G. Satała at all, J. Enzyme Inhib. Med. Chem. 31 (2016) 1048 (

H. Chen, F. Xu, X. Liang, B.B. Xu, Z. L. Yang, X.L. He, B.Y. Huang, M. Yuan, Bioorg. Med. Chem. Lett. 25 (2015) 285 (

M. Shaquiquzzaman, G. Verma, A. Marella, M. Akhter, W. Akhtar, M. F. Khan, S. Tasneem, M. M. Alam, Eur. J. Med. Chem. 102 (2015) 487 (

S. Wang, T. Che, A. Levit, B. K. Shoichet, D. Wacker, B. L. Roth, Nature 555 (2018) 269 (

H. Vogel, Drug Discovery and Evaluation – Pharmacological Assays, Springer, Berlin, Germany, 2002, p.501 ISBN: 978-3540423966

E. Therrien, P. Englebienne, A. G. Arrowsmith, R. Mendoza-Sanchez, C. R. Corbeil, N. Weill, et al., J. Chem. Inf. Model. 52 (2012) 210 (

RCSB PDB Protein Data Bank,, (accessed june 2018.)

D. A. Evans, Angew. Chemie Int. Ed. 53 (2014) 11140 (

Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY, 2018 Maestro-Desmond Interoperability Tools, Schrödinger, New York, NY, 2018

Orientations of Proteins in Membranes (OPM) database,, (accessed May 2018)

W. L. Jorgensen, J. Tirado-Rives, J. Am. Chem. Soc., 110 (1988) 1657 (

D. J. Evans, B. L. Holian, J. Chem. Phys. 83 (1998) 4069 (

G. J. Martyna, D. J. Tobias, M. L. Klein, J. Chem. Phys. 101 (1998) 4177 (

V. P. Vasić, J. Z. Penjišević, I. T. Novaković, V. V. Šukalović, D. B. Andrić, S. V. Kostić-Rajačić, J. Serb. Chem. Soc. 79 (2014) 277 (

D. Andrić, G. Roglić, V. Šukalović, V. Šoškić, S. Kostić-Rajačić, Eur. J. Med. Chem. 43 (2008) 1696 (

J. Z. Penjišević, V. V. Šukalović, D. B. Andrić, G. M. Roglić, I. T. Novaković, V. Šoškić, S. V. Kostić-Rajačić, J. Serb. Chem. Soc. 81 (2016) 347 (


Copyright (c) 2018 J. Serb. Chem. Soc.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

IMPACT FACTOR 0.797 (139 of 171 journals)
5 Year Impact Factor 0,923 (134 of 171 journals)